Robert Casey actually said...

I am concerned that progress on these technologies could be slowed by insufficient face-to-face communication--the intention for these meeti...

I have been particularly excited to hear about tremendous progress in the area of cell and gene therapy and the promise they hold in curing ...

key among these challenges is reaching agreement with regulators about determining the appropriate efficacy endpoints to support approval of...

We need creative ideas that can realign current market incentives to encourage drug developers to stay in this business.